Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer

Jingjing Wu; Wen Xu; Lina Ma; Jiayu Sheng; Meina Ye; Hao Chen; Yuzhu Zhang; Bing Wang; Mingjuan Liao; Tian Meng; Yue Zhou; Hongfeng Chen

doi:doi:10.18632/aging.203156

← Back

Research Paper Volume 13, Issue 14 pp 18191—18222

Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer

Figure 5. MiR-195 interfered with the influence of lncRNA AFAP1-AS1 on drug-resistance (A–D), proliferation (E), migration (F) and invasion (G) of triple-negative breast cancer (TNBC) cells. *: P<0.05.